ReviewFrontiers in pharmacology2025

Dipeptidyl peptidase 1 inhibitors for inflammatory respiratory diseases: mechanisms, clinical trials, and therapeutic prospects.

Dandan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.